Financial Advisory Group’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $350K | Hold |
31,417
| – | – | 0.06% | 72 |
|
|
2023
Q4 | $468K | Hold |
31,417
| – | – | 0.09% | 62 |
|
|
2023
Q3 | $151K | Hold |
31,417
| – | – | 0.03% | 81 |
|
|
2023
Q2 | $236K | Hold |
31,417
| – | – | 0.05% | 76 |
|
|
2023
Q1 | $142K | Hold |
31,417
| – | – | 0.03% | 87 |
|
|
2022
Q4 | $354K | Hold |
31,417
| – | – | 0.08% | 66 |
|
|
2022
Q3 | $301K | Hold |
31,417
| – | – | 0.07% | 70 |
|
|
2022
Q2 | $254K | Hold |
31,417
| – | – | 0.05% | 76 |
|
|
2022
Q1 | $531K | Hold |
31,417
| – | – | 0.1% | 54 |
|
|
2021
Q4 | $675K | Hold |
31,417
| – | – | 0.13% | 50 |
|
|
2021
Q3 | $2.32M | Sell |
31,417
-22,624
| -42% | -$1.67M | 0.51% | 24 |
|
|
2021
Q2 | $2.96M | Buy |
+54,041
| New | +$2.96M | 0.71% | 18 |
|